Home NDC 71610-188-80 Gabapentin
Product NDC 71610-188
Requested package NDC 71610-188-80
11-digit product format 716100188
Labeler code 71610
Product ID 71610-188_33d95ef3-e1a3-44e5-91e6-3e333e272de2
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Gabapentin
Dosage form CAPSULE
Route ORAL
Labeler Aphena Pharma Solutions - Tennessee, LLC
Application ANDA078787
Marketing category ANDA
Marketing start 2008-01-31
Substance GABAPENTIN
Active strength 300 mg/1
Pharmacologic classes Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A078787-001 GABAPENTIN GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 A078787-002 GABAPENTIN GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 A078787-003 GABAPENTIN GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 135 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A078787-002 GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A078787-003 GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 A078787-002 GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 A078787-003 GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31 c2088c7a36db…2026-09-14 22:38:34 2026-08 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 A078787-002 GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 A078787-003 GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31 84e616aacf4f…2026-08-18 06:07:40 2026-07 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078787-002 GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078787-003 GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078787-002 GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078787-003 GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078787-002 GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078787-003 GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078787-002 GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078787-003 GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078787-002 GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078787-003 GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078787-002 GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078787-003 GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078787-002 GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078787-003 GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A078787-002 GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A078787-003 GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A078787-002 GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A078787-003 GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A078787-002 GABAPENTIN 300MG CAPSULE / ORAL AB 2008-01-31 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A078787-003 GABAPENTIN 400MG CAPSULE / ORAL AB 2008-01-31 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A078787-001 GABAPENTIN 100MG CAPSULE / ORAL AB 2008-01-31 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 135 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Gabapentin
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength GABAPENTIN 300 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 6CW7F3G59X Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 310431 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71610-188 GABAPENTIN CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 Current NDC, Legacy NDC, 7 package rows 20200815_3b4395f2-9440-4b67-97cc-5d16f3bdd05e.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 2 · 21 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Gabapentin GABAPENTIN Aphena Pharma Solutions - Tennessee, LLC 5fbd601f-df95-4a79-a7d3-c3505e23b913 2018-09-06 Warnings, Adverse reactions Exact identifier application applno (ANDA): 078787 application number: ANDA078787
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 71610-188-80 71610018880 180 CAPSULE in 1 BOTTLE (71610-188-80) 180 capsule 2018-11-05 0000-00-00 No No Current